Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Clin Immunol. 2011 Mar;7(2):227-41. doi: 10.1586/eci.10.98.

Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Author information

  • 1Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA. mmcmahon@mednet.ucla.edu

Abstract

Patients with systemic lupus erythematosus have a significantly increased risk of cardiovascular events due to atherosclerosis. Traditional cardiac risk factors cannot fully explain this increased risk. Recent evidence strongly suggests that atherosclerotic plaque is largely driven by inflammation and an active immunological response, in contrast to the long-held belief that plaque is a passive accumulation of lipids in the arterial wall. Current approaches to the prevention of atherosclerosis in systemic lupus erythematosus involve targeting modifiable cardiac risk factors. Future preventive strategies may include therapies that counteract the immunologic responses that lead to plaque formation.

PMID:
21426260
[PubMed - indexed for MEDLINE]
PMCID:
PMC3718673
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Informa Healthcare Icon for PubMed Central
    Loading ...
    Write to the Help Desk